WHO starts trial of multiple Ebola vaccines in DR Congo

In short

• The WHO announced the start of an Ebola vaccine clinical trial in DR Congo.
• The trial will test the safety, efficacy and immunogenicity of multiple vaccines.
• The source gives no trial size, timeline or results yet.

Why the Good News Desk likes this one

The trial is at an early stage, and the source does not say how many people will take part or when results will come. Its purpose is to test several candidate vaccines for safety, efficacy and immunogenicity. A vaccine that passes these tests could help protect people in future Ebola outbreaks.

Ask this story

Answers come only from the material behind this story, with a link to the source.